---
title: "CITIC: CITIC Pacific Special Steel's net profit attributable to shareholders for the first three quarters is approximately 4.33 billion yuan, a year-on-year increase of 12.88%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262590657.md"
description: "According to the Zhitong Finance APP, CITIC announced the performance of CITIC Pacific Special Steel for the first three quarters of 2025, with operating revenue of approximately 81.206 billion yuan, a year-on-year decrease of 2.75%; net profit attributable to shareholders of the listed company was approximately 4.33 billion yuan, a year-on-year increase of 12.88%; basic earnings per share were 0.858 yuan"
datetime: "2025-10-24T10:07:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262590657.md)
  - [en](https://longbridge.com/en/news/262590657.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262590657.md)
---

# CITIC: CITIC Pacific Special Steel's net profit attributable to shareholders for the first three quarters is approximately 4.33 billion yuan, a year-on-year increase of 12.88%

According to the Zhitong Finance APP, CITIC (00267) announced the performance of CITIC Pacific Special Steel (000708.SZ) for the first three quarters of 2025, with operating revenue of approximately 81.206 billion yuan, a year-on-year decrease of 2.75%; net profit attributable to shareholders of the listed company was approximately 4.33 billion yuan, a year-on-year increase of 12.88%; basic earnings per share were 0.858 yuan

### Related Stocks

- [00267.HK](https://longbridge.com/en/quote/00267.HK.md)
- [000708.CN](https://longbridge.com/en/quote/000708.CN.md)

## Related News & Research

- [REG - RNS - Final Announcement Released](https://longbridge.com/en/news/294722502.md)
- [Chongqing Iron & Steel Finalises Capital Injection into Baowu Units After Valuation Adjustments](https://longbridge.com/en/news/294550514.md)
- [Xinming China Completes HK$106 Million Rights Issue and Placing](https://longbridge.com/en/news/294549778.md)
- [REG - Odyssean Inv. Trust - Issue of Equity](https://longbridge.com/en/news/294713283.md)
- [Shaanxi Micot’s Stroke Drug MT200605 Hits Phase II Milestone, Bolstering Neuro Portfolio](https://longbridge.com/en/news/294726089.md)